Clinical trial
Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation (NVAF)
NCT02951039 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation (NVAF)
- Lead sponsor
- Daiichi Sankyo
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 21, 2017
- Completion date
- October 15, 2020
- Enrollment
- 3,008 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.